Granules said on December 22, 2025 it had received a tentative approval for the Amphetamine Extended-Release Orally ...
Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India, has received Tentative Approval (TA) from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug ...